Discount Agreement for Vareniclin (ATC N07BA03)
Notice title: Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Vareniclin, ATC N07BA03 für die Zeit 01.08.2026 - 31.07.2028 (zzgl. Verlängerungsoption 1x12 Monate)
Status
Active
Submission Deadline
974 days remaining
Contracting authority
Location
Hamburg, Germany
Estimated Value
€1
Procedure
Open Procedure · Supplies
Category
Pharmaceutical products.
Published
Reference
bkms-ef-76d022d6-d5ea-463c-93d4-51e4592b120b
Source
DAK-Gesundheit is entering into non-exclusive discount agreements for Vareniclin (ATC N07BA03) to facilitate access for all interested pharmaceutical companies. The agreements are valid from 01.08.2026 to 31.07.2028 with an extension option.
Free
Never miss a tender again
We send you 3 current matches that fit your company.
Tender documents
- SomeTenderDocID1NON-RESTRICTED-DOCUMENT
Free
Unlock documents for free
Enter your email address. If you confirm, we will also send you 3 similar tenders.
Additional details
Legal Basis
32014L0024